Glipizide · GLIPIZIDE 10 mg/1 · Tablet, Extended Release · Oral · Northstar Rx LLC.
NDC 16714-0896-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
9 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 16% over the past year, to $0.1226 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market · price up 1% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | GLIPIZIDE 2.5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | GLIPIZIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC. | GLIPIZIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC. | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC. | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | GLIPIZIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Roerig | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| St. Mary's Medical Park Pharmacy | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| St. Mary's Medical Park Pharmacy | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | GLIPIZIDE 10 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Aurobindo Pharma Limited | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
| Roerig | GLIPIZIDE 5 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Glipizide — NDC 16714-0896-01," retrieved September 3, 2026, https://drugdashboards.com/drug/16714089601.
Free to cite with attribution — see how the data is put together.